Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Adicet Bio, Inc.(ACET US)

$3.99-0.296.78%Ext:$4.42+0.4310.85%(Market Closed · 00:00:05 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
ACET US​

SEC Filings

Financials(38)

Expand
  • 10-QQ2ended 30 Jun 20265 Aug
  • 10-K/AFY 2025ended 31 Dec 202520 May
  • 10-QQ1ended 31 Mar 202613 May
  • 10-KFY 2025ended 31 Dec 202512 Mar
  • 10-QQ3ended 30 Sept 20255 Nov 2025
  • 10-QQ2ended 30 Jun 20257 Aug 2025
  • 10-QQ1ended 31 Mar 20256 May 2025
  • 10-KFY 2024ended 31 Dec 20246 Mar 2025
  • 10-QQ3ended 30 Sept 20246 Nov 2024
  • 10-QQ2ended 30 Jun 202413 Aug 2024
  • 10-QQ1ended 31 Mar 202414 May 2024
  • 10-KFY 2023ended 31 Dec 202319 Mar 2024
  • 10-QQ3ended 30 Sept 20238 Nov 2023
  • 10-QQ2ended 30 Jun 20239 Aug 2023
  • 10-QQ1ended 31 Mar 20239 May 2023

Events(150)

Expand
  • 8-KRegulation FD Disclosure28 Sep
  • 8-KRegulation FD Disclosure8 Sep
  • 8-KRegulation FD Disclosure1 Sep
  • 8-KResults of Operations and Financial Condition5 Aug
  • 8-KSubmission of Matters to a Vote of Security Holders18 Jun
  • 8-KResults of Operations and Financial Condition13 May
  • 8-KUnregistered Sales of Equity Securities28 Apr
  • 8-KResults of Operations and Financial Condition12 Mar
  • 8-KRegulation FD Disclosure7 Jan
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year29 Dec 2025
  • 8-KSubmission of Matters to a Vote of Security Holders19 Dec 2025
  • 8-KResults of Operations and Financial Condition5 Nov 2025
  • 8-KDelisting/Non-Compliance Notice; Listing Transfer7 Oct 2025
  • 8-KEntry into Material Agreement7 Oct 2025
  • 8-KOther Events7 Oct 2025

Insider Ownership(288)

Expand
  • 4Statement of changes in beneficial ownership7 Aug
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4Statement of changes in beneficial ownership23 Jun
  • 4RA Capital Healthcare Fund LP29 Apr
  • 4RA Capital Healthcare Fund LP13 Apr
  • 3RA Capital Healthcare Fund LP13 Apr
  • 4OrbiMed Israel GP Ltd.9 Apr
  • 4Statement of changes in beneficial ownership27 Mar
  • 4Statement of changes in beneficial ownership27 Mar

Beneficial Ownership(79)

Expand
  • SC 13GAdicet Bio, Inc.23 Oct
  • SC 13G/AAdicet Bio, Inc.14 Aug
  • SC 13G/AAdicet Bio, Inc.15 May
  • SC 13G/AAdicet Bio, Inc.13 Apr
  • SC 13D/AAdicet Bio, Inc.10 Apr
  • SC 13G/AAdicet Bio, Inc.17 Feb
  • SC 13G/AAdicet Bio, Inc.17 Feb
  • SC 13GAdicet Bio, Inc.17 Feb
  • SC 13GAdicet Bio, Inc.29 Jan
  • SC 13D/AAdicet Bio, Inc.10 Oct 2025
  • SC 13G/AAdicet Bio, Inc.15 May 2025
  • SC 13G/AAdicet Bio, Inc.14 Nov 2024
  • SC 13G/AAdicet Bio, Inc.14 Nov 2024
  • SC 13G/AAdicet Bio, Inc.14 Nov 2024
  • SC 13G/AAdicet Bio, Inc.14 Nov 2024

Other Ownership(5)

Expand
  • 144ORBIMED ADVISORS LLC9 Apr
  • 144OrbiMed Advisors Israel II Ltd8 Apr
  • 144OrbiMed Israel GP Ltd.7 Apr
  • 144Kauffman Michael5 Jun 2024
  • 144Schor Chen29 Sep 2023

Proxies(25)

Expand
  • ARSAnnual report to security holders29 Apr
  • DEFA14ADefinitive additional materials29 Apr
  • DEF 14ADefinitive proxy statement29 Apr
  • DEF 14ADefinitive proxy statement17 Nov 2025
  • PRE 14APreliminary proxy statement5 Nov 2025
  • ARSAnnual report to security holders29 Apr 2025
  • DEFA14ADefinitive additional materials29 Apr 2025
  • DEF 14ADefinitive proxy statement29 Apr 2025
  • DEFR14ADefinitive revised proxy statement26 Apr 2024
  • ARSAnnual report to security holders24 Apr 2024
  • DEFA14ADefinitive additional materials23 Apr 2024
  • DEF 14ADefinitive proxy statement23 Apr 2024
  • PRE 14APreliminary proxy statement12 Apr 2024
  • DEFA14ADefinitive additional materials21 Apr 2022
  • DEF 14ADefinitive proxy statement21 Apr 2022

Registrations(60)

Expand
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8Registration statement (employee benefit plan)12 Mar
  • S-3Registration statement (primary offering)12 Mar
  • 424B5Prospectus filing (Rule 424(b)(5))7 Oct 2025
  • S-8Registration statement (employee benefit plan)25 Jul 2025
  • S-8 POSPost-effective amendment (employee benefit plan)26 Mar 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Mar 2025
  • S-3Registration statement (primary offering)6 Mar 2025
  • S-8Registration statement (employee benefit plan)6 Mar 2025
  • 424B5Prospectus filing (Rule 424(b)(5))22 Mar 2024
  • S-8 POSPost-effective amendment (employee benefit plan)19 Mar 2024
  • S-8Registration statement (employee benefit plan)19 Mar 2024
  • 424B5Prospectus filing (Rule 424(b)(5))24 Jan 2024
  • 424B5Prospectus filing (Rule 424(b)(5))22 Jan 2024
  • S-8 POSPost-effective amendment (employee benefit plan)9 Aug 2023

Filing Review Correspondence(14)

Expand
  • CORRESPFiling review correspondence19 Mar
  • CORRESPFiling review correspondence12 Mar 2025
  • CORRESPFiling review correspondence5 May 2022
  • CORRESPFiling review correspondence19 May 2021
  • CORRESPFiling review correspondence26 Mar 2021
  • CORRESPFiling review correspondence19 Aug 2020
  • CORRESPFiling review correspondence12 Aug 2020
  • CORRESPFiling review correspondence29 Jul 2020
  • CORRESPFiling review correspondence8 Feb 2019
  • CORRESPFiling review correspondence23 Jan 2018
  • CORRESPFiling review correspondence23 Jan 2018
  • CORRESPFiling review correspondence5 Jan 2018
  • DRSLTRFiling review correspondence (DRSLTR)22 Dec 2017
  • DRSLTRFiling review correspondence (DRSLTR)1 Dec 2017

SEC Orders And Notices(9)

Expand
  • EFFECTNotice of effectiveness24 Mar
  • EFFECTNotice of effectiveness14 Mar 2025
  • EFFECTNotice of effectiveness9 May 2022
  • EFFECTNotice of effectiveness21 May 2021
  • EFFECTNotice of effectiveness30 Mar 2021
  • EFFECTNotice of effectiveness20 Aug 2020
  • EFFECTNotice of effectiveness12 Feb 2019
  • CT ORDERConfidential treatment order25 Jan 2018
  • EFFECTNotice of effectiveness25 Jan 2018

Other(1)

Expand
  • CERTCERT25 Jan 2018